Your session is about to expire
← Back to Search
Genomic Biorepository for Genetic Disorders
N/A
Recruiting
Led By Stephen Kingsmore, MD, MSc
Research Sponsored by Rady Pediatric Genomics & Systems Medicine Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion estimated to be 40 years
Awards & highlights
Study Summary
This trial is collecting biological samples and clinical features from patients in order to create a standardized resource for future research studies on childhood diseases. The repository will also be used to confirm diagnoses of genetic diseases.
Who is the study for?
The Rady Children's Institute Genomic Biorepository is open to individuals of all ages, races, genders, ethnicities, and health statuses. It includes vulnerable groups such as pregnant women, neonates, fetuses, those with cognitive disabilities, children, minorities, and employees. There are no exclusion criteria.Check my eligibility
What is being tested?
This trial involves collecting biological samples for genomic sequencing to research the genetic causes and treatments of childhood diseases. The data may also be used in future as a reference for improving clinical diagnoses or decisions.See study design
What are the potential side effects?
Since this study involves genomic sequencing without direct medical interventions like drugs or surgery there are typically no side effects associated with participating in this type of research.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion estimated to be 40 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion estimated to be 40 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of samples enrolled per year
Secondary outcome measures
Proportion of children in which human phenotype ontology (HPO) terms accurately predict molecular diagnosis
Proportion of children receiving molecular diagnoses
Time taken to receive molecular diagnosis
Trial Design
1Treatment groups
Experimental Treatment
Group I: EnrolleesExperimental Treatment1 Intervention
Enrollment of healthy and affected subjects to collect samples and data for a pediatric genomic Biorepository. Data includes genomic sequencing and resultant molecular diagnostic results, if any.
Find a Location
Who is running the clinical trial?
Rady Pediatric Genomics & Systems Medicine InstituteLead Sponsor
8 Previous Clinical Trials
111,853 Total Patients Enrolled
Stephen Kingsmore, MD, MScPrincipal InvestigatorRady Pediatric Genomics & Systems Medicine Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am of any age, race, gender, ethnicity, and health status.N/ACertain groups of people may not be eligible to participate in the study, including pregnant women, newborn babies, individuals with learning or developmental disabilities, children, people from minority groups, and employees.
Research Study Groups:
This trial has the following groups:- Group 1: Enrollees
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the aggregate tally of participants in this research venture?
"Indeed, clinicaltrials.gov data suggests that this medical experiment is now recruiting patients. Originally made public on July 1st 2016, the study was most recently updated on May 24th 2019 and seeks 102000 persons from a single trial centre."
Answered by AI
Is this experiment actively seeking participants at this time?
"Per the details on clinicaltrials.gov, this medical trial is presently seeking patients. It was initially advertised on July 1st 2016 and received its most recent update on May 24th 2019."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger